assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001889485.1_ASM188948v1	NZ_CP018190	Granulibacter bethesdensis strain NIH5.1 chromosome, complete genome	1	1522948-1525233	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,cas3	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	Type I-E	CGGTTCATCCCCGCGCAGGCGGGGAACAC,CGGTTCATCCCCGCGCAGGCGGGGAACAC,CGGTTCATCCCCGCGCAGGCGGGGAACAC	29,29,29	0	0	NA	NA	I-E:I-E:I-E	37,37,37	37	TypeI-E	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	NA|53aa|up_7|NZ_CP018190.1_1515455_1515614_-,NA	NA|190aa|up_9|NZ_CP018190.1_1514640_1515210_+	pfam06242, DUF1013, Protein of unknown function (DUF1013)	NA|61aa|up_8|NZ_CP018190.1_1515295_1515478_-	pfam04325, DUF465, Protein of unknown function (DUF465)	NA|53aa|up_7|NZ_CP018190.1_1515455_1515614_-	NA	NA|68aa|up_6|NZ_CP018190.1_1515693_1515897_+	COG5481, COG5481, Uncharacterized conserved small protein containing a coiled-coil domain [Function unknown]	NA|174aa|up_5|NZ_CP018190.1_1515901_1516423_+	pfam00731, AIRC, AIR carboxylase	NA|380aa|up_4|NZ_CP018190.1_1516432_1517572_+	PRK06019, PRK06019, phosphoribosylaminoimidazole carboxylase ATPase subunit; Reviewed	NA|405aa|up_3|NZ_CP018190.1_1517767_1518982_+	PRK08299, PRK08299, NADP-dependent isocitrate dehydrogenase	NA|274aa|up_2|NZ_CP018190.1_1519023_1519845_+	COG0412, COG0412, Dienelactone hydrolase and related enzymes [Secondary metabolites biosynthesis, transport, and catabolism]	NA|65aa|up_1|NZ_CP018190.1_1519919_1520114_-	pfam01679, Pmp3, Proteolipid membrane potential modulator	NA|881aa|up_0|NZ_CP018190.1_1520209_1522852_-	PRK00252, alaS, alanyl-tRNA synthetase; Reviewed	cas2|96aa|down_0|NZ_CP018190.1_1525304_1525592_-	PRK11558, PRK11558, putative ssRNA endonuclease; Provisional	cas1|316aa|down_1|NZ_CP018190.1_1525588_1526536_-	TIGR03638, cas1_ECOLI, CRISPR-associated endonuclease Cas1, subtype I-E/ECOLI	cas6e|228aa|down_2|NZ_CP018190.1_1526535_1527219_-	smart01101, CRISPR_assoc, This domain forms an anti-parallel beta strand structure with flanking alpha helical regions	cas5|226aa|down_3|NZ_CP018190.1_1527220_1527898_-	cd09645, Cas5_I-E, CRISPR/Cas system-associated RAMP superfamily protein Cas5	cas7|355aa|down_4|NZ_CP018190.1_1527894_1528959_-	pfam09344, Cas_CT1975, CT1975-like protein	cse2gr11|166aa|down_5|NZ_CP018190.1_1528958_1529456_-	cd09731, Cse2_I-E, CRISPR/Cas system-associated protein Cse2	cas8e|486aa|down_6|NZ_CP018190.1_1529452_1530910_-	cd09729, Cse1_I-E, CRISPR/Cas system-associated protein Cse1	cas3|833aa|down_7|NZ_CP018190.1_1531283_1533782_-	PRK09694, PRK09694, CRISPR-associated helicase/endonuclease Cas3	NA|148aa|down_8|NZ_CP018190.1_1534647_1535091_-	PRK06848, PRK06848, cytidine deaminase	NA|346aa|down_9|NZ_CP018190.1_1535110_1536148_-	PRK09354, recA, recombinase A; Provisional
GCF_001889485.1_ASM188948v1	NZ_CP018190	Granulibacter bethesdensis strain NIH5.1 chromosome, complete genome	2	1534179-1534572	2,2,2	PILER-CR,CRISPRCasFinder,CRT	no	cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,cas3	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	Type I-E	GGTTCCCCCGCGTGCGCGGGGATAGTCC,GGACTATCCCCGCGCACGCGGGGGAACC,GGACTATCCCCGCGCACGCGGGGGAACC	28,28,28	0	0	NA	NA	NA:NA:NA	6,6,6	6	TypeI-E	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	NA,NA|81aa|down_6|NZ_CP018190.1_1540060_1540303_-,NA|307aa|down_7|NZ_CP018190.1_1540310_1541231_+,NA|72aa|down_8|NZ_CP018190.1_1541661_1541877_-	NA|65aa|up_9|NZ_CP018190.1_1519919_1520114_-	pfam01679, Pmp3, Proteolipid membrane potential modulator	NA|881aa|up_8|NZ_CP018190.1_1520209_1522852_-	PRK00252, alaS, alanyl-tRNA synthetase; Reviewed	cas2|96aa|up_7|NZ_CP018190.1_1525304_1525592_-	PRK11558, PRK11558, putative ssRNA endonuclease; Provisional	cas1|316aa|up_6|NZ_CP018190.1_1525588_1526536_-	TIGR03638, cas1_ECOLI, CRISPR-associated endonuclease Cas1, subtype I-E/ECOLI	cas6e|228aa|up_5|NZ_CP018190.1_1526535_1527219_-	smart01101, CRISPR_assoc, This domain forms an anti-parallel beta strand structure with flanking alpha helical regions	cas5|226aa|up_4|NZ_CP018190.1_1527220_1527898_-	cd09645, Cas5_I-E, CRISPR/Cas system-associated RAMP superfamily protein Cas5	cas7|355aa|up_3|NZ_CP018190.1_1527894_1528959_-	pfam09344, Cas_CT1975, CT1975-like protein	cse2gr11|166aa|up_2|NZ_CP018190.1_1528958_1529456_-	cd09731, Cse2_I-E, CRISPR/Cas system-associated protein Cse2	cas8e|486aa|up_1|NZ_CP018190.1_1529452_1530910_-	cd09729, Cse1_I-E, CRISPR/Cas system-associated protein Cse1	cas3|833aa|up_0|NZ_CP018190.1_1531283_1533782_-	PRK09694, PRK09694, CRISPR-associated helicase/endonuclease Cas3	NA|148aa|down_0|NZ_CP018190.1_1534647_1535091_-	PRK06848, PRK06848, cytidine deaminase	NA|346aa|down_1|NZ_CP018190.1_1535110_1536148_-	PRK09354, recA, recombinase A; Provisional	NA|163aa|down_2|NZ_CP018190.1_1536502_1536991_+	TIGR03330, SAM_DCase_Bsu, S-adenosylmethionine decarboxylase proenzyme, Bacillus form	NA|294aa|down_3|NZ_CP018190.1_1537113_1537995_+	PRK00811, PRK00811, polyamine aminopropyltransferase	NA|138aa|down_4|NZ_CP018190.1_1538130_1538544_-	TIGR02420, RNA_polymerase-binding_transcription_factor_DksA, RNA polymerase-binding protein DksA	NA|323aa|down_5|NZ_CP018190.1_1539001_1539970_+	cd03801, GT4_PimA-like, phosphatidyl-myo-inositol mannosyltransferase	NA|81aa|down_6|NZ_CP018190.1_1540060_1540303_-	NA	NA|307aa|down_7|NZ_CP018190.1_1540310_1541231_+	NA	NA|72aa|down_8|NZ_CP018190.1_1541661_1541877_-	NA	NA|177aa|down_9|NZ_CP018190.1_1541918_1542449_+	PRK02853, PRK02853, hypothetical protein; Provisional
GCF_001889485.1_ASM188948v1	NZ_CP018190	Granulibacter bethesdensis strain NIH5.1 chromosome, complete genome	3	1832443-1835948	3,3,3	CRISPRCasFinder,CRT,PILER-CR	no		csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	Orphan	GGTCTATCTCCGCGCACGCGGAGGAACC,GGTCTATCTCCGCGCACGCGGAGGAACC,GGTTCCTCCGCGTGCGCGGAGATAGACC	28,28,28	0	0	NA	NA	NA:NA:NA	57,57,55	57	Orphan	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	NA|77aa|up_8|NZ_CP018190.1_1823013_1823244_+,NA	NA|616aa|up_9|NZ_CP018190.1_1821146_1822994_+	COG0370, FeoB, Fe2+ transport system protein B [Inorganic ion transport and metabolism]	NA|77aa|up_8|NZ_CP018190.1_1823013_1823244_+	NA	NA|337aa|up_7|NZ_CP018190.1_1823471_1824482_+	cd12834, ZntB_u1, Uncharacterized bacterial subgroup of the Salmonella typhimurium Zn2+ transporter ZntB-like subfamily	NA|306aa|up_6|NZ_CP018190.1_1824596_1825514_+	TIGR03707, PPK2_P_aer, polyphosphate kinase 2, PA0141 family	NA|254aa|up_5|NZ_CP018190.1_1825558_1826320_-	PRK10621, PRK10621, hypothetical protein; Provisional	NA|330aa|up_4|NZ_CP018190.1_1826496_1827486_-	pfam14613, DUF4449, Protein of unknown function (DUF4449)	NA|213aa|up_3|NZ_CP018190.1_1827740_1828379_-	pfam04264, YceI, YceI-like domain	NA|342aa|up_2|NZ_CP018190.1_1828641_1829667_+	COG1087, GalE, UDP-glucose 4-epimerase [Cell envelope biogenesis, outer membrane]	NA|249aa|up_1|NZ_CP018190.1_1829791_1830538_+	cd02432, Nodulin-21_like_1, Nodulin-21 and CCC1-related protein family	NA|571aa|up_0|NZ_CP018190.1_1830534_1832247_-	COG1132, MdlB, ABC-type multidrug transport system, ATPase and permease components [Defense mechanisms]	NA|407aa|down_0|NZ_CP018190.1_1836479_1837700_-	COG0617, PcnB, tRNA nucleotidyltransferase/poly(A) polymerase [Translation, ribosomal structure and biogenesis]	NA|219aa|down_1|NZ_CP018190.1_1837717_1838374_-	cd03426, CoAse, Coenzyme A pyrophosphatase (CoAse), a member of the Nudix hydrolase superfamily, functions to catalyze the elimination of oxidized inactive CoA, which can inhibit CoA-utilizing enzymes	NA|180aa|down_2|NZ_CP018190.1_1838377_1838917_-	pfam06938, DUF1285, Protein of unknown function (DUF1285)	NA|469aa|down_3|NZ_CP018190.1_1839142_1840549_-	TIGR03173, pbuX, xanthine permease	NA|305aa|down_4|NZ_CP018190.1_1840714_1841629_+	cd08426, PBP2_LTTR_like_5, The C-terminal substrate binding domain of an uncharacterized LysR-type transcriptional regulator, contains the type 2 periplasmic binding fold	NA|343aa|down_5|NZ_CP018190.1_1841715_1842744_+	COG0714, COG0714, MoxR-like ATPases [General function prediction only]	NA|300aa|down_6|NZ_CP018190.1_1842755_1843655_+	COG1721, COG1721, Uncharacterized conserved protein (some members contain a von Willebrand factor type A (vWA) domain) [General function prediction only]	NA|955aa|down_7|NZ_CP018190.1_1843668_1846533_+	pfam13709, DUF4159, Domain of unknown function (DUF4159)	NA|753aa|down_8|NZ_CP018190.1_1846545_1848804_+	pfam07090, GATase1_like, Putative glutamine amidotransferase	NA|170aa|down_9|NZ_CP018190.1_1848903_1849413_+	cd15904, TSPO_MBR, Translocator protein (TSPO)/peripheral-type benzodiazepine receptor (MBR) family
GCF_001889485.1_ASM188948v1	NZ_CP018190	Granulibacter bethesdensis strain NIH5.1 chromosome, complete genome	4	1918110-1920577	4,4,4	PILER-CR,CRISPRCasFinder,CRT	no	cas3,cas8e,cse2gr11,cas7,cas5,cas6e,cas1,cas2	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	Type I-E	GGTTCCTCCGCGTGCGCGGAGATAGACC,GGTTCCTCCGCGTGCGCGGAGATAGACC,GGTTCCTCCGCGTGCGCGGAGATAGACC	28,28,28	1	1	1920273-1920305	NZ_CP018190.1_2649979-2650011	NA:NA:NA	40,40,40	40	TypeI-E	csa3,cas3,cas2,cas1,cas6e,cas5,cas7,cse2gr11,cas8e,DEDDh,DinG	NA,NA|63aa|down_4|NZ_CP018190.1_1923982_1924171_-	NA|249aa|up_9|NZ_CP018190.1_1907741_1908488_+	COG1989, PulO, Type II secretory pathway, prepilin signal peptidase PulO and related peptidases [Cell motility and secretion / Posttranslational modification, protein turnover, chaperones / Intracellular trafficking and secretion]	NA|219aa|up_8|NZ_CP018190.1_1908500_1909157_-	COG1280, RhtB, Putative threonine efflux protein [Amino acid transport and metabolism]	cas3|850aa|up_7|NZ_CP018190.1_1909417_1911967_+	PRK09694, PRK09694, CRISPR-associated helicase/endonuclease Cas3	cas8e|522aa|up_6|NZ_CP018190.1_1912129_1913695_+	TIGR02547, CRISPR_system_Cascade_subunit_CasA, CRISPR type I-E/ECOLI-associated protein CasA/Cse1	cse2gr11|191aa|up_5|NZ_CP018190.1_1913681_1914254_+	cd09731, Cse2_I-E, CRISPR/Cas system-associated protein Cse2	cas7|387aa|up_4|NZ_CP018190.1_1914246_1915407_+	pfam09344, Cas_CT1975, CT1975-like protein	cas5|236aa|up_3|NZ_CP018190.1_1915403_1916111_+	TIGR01868, hypothetical_protein, CRISPR-associated protein Cas5/CasD, subtype I-E/ECOLI	cas6e|248aa|up_2|NZ_CP018190.1_1916110_1916854_+	smart01101, CRISPR_assoc, This domain forms an anti-parallel beta strand structure with flanking alpha helical regions	cas1|300aa|up_1|NZ_CP018190.1_1916857_1917757_+	cd09719, Cas1_I-E, CRISPR/Cas system-associated protein Cas1	cas2|98aa|up_0|NZ_CP018190.1_1917756_1918050_+	pfam09707, Cas_Cas2CT1978, CRISPR-associated protein (Cas_Cas2CT1978)	NA|105aa|down_0|NZ_CP018190.1_1921034_1921349_+	PRK05573, rplU, 50S ribosomal protein L21; Validated	NA|90aa|down_1|NZ_CP018190.1_1921362_1921632_+	PRK05435, rpmA, 50S ribosomal protein L27; Validated	NA|344aa|down_2|NZ_CP018190.1_1921796_1922828_+	PRK12299, obgE, GTPase CgtA; Reviewed	NA|382aa|down_3|NZ_CP018190.1_1922824_1923970_+	PRK05429, PRK05429, gamma-glutamyl kinase; Provisional	NA|63aa|down_4|NZ_CP018190.1_1923982_1924171_-	NA	NA|422aa|down_5|NZ_CP018190.1_1924368_1925634_+	PRK00197, proA, gamma-glutamyl phosphate reductase; Provisional	NA|229aa|down_6|NZ_CP018190.1_1925637_1926324_+	PRK00071, nadD, nicotinate-nucleotide adenylyltransferase	NA|151aa|down_7|NZ_CP018190.1_1926494_1926947_+	pfam02410, RsfS, Ribosomal silencing factor during starvation	NA|158aa|down_8|NZ_CP018190.1_1926987_1927461_+	cd18081, RlmH-like, 23S-rRNA-pseudouridine1915-N3-methyltransferase RlmH	NA|503aa|down_9|NZ_CP018190.1_1927594_1929103_+	PRK05434, PRK05434, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
